PFM Health Sciences, LP Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001442756

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallHealth TiltHigh Turnover how tags are computed

Q1 2026 · 78 positions · Total reported value $987.91M · Top-10 concentration 43.1% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 75.8% · 24 new · 28 cut · 39 exited

Active Share (vs S&P 500): 96.6% · vs QQQ: 99.7% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -4.9% · vs SPY -7.0% · Prev Value $1.14B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): +2.3% · vs SPY +0.2% · Latest Value $978.49M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q1 2026 13F filing, PFM Health Sciences, LP disclosed 78 equity positions with a combined reported value of $987.91M. The filing implies a moderately concentrated portfolio: its ten largest positions account for 43.1% of reported value. HoldingsHub classifies the profile as Small / Health Tilt / High Turnover.

The largest disclosed positions as of Q1 2026 were THC ($75.21M), LLY ($60.49M), XBI ($58.16M). By sector, the heaviest allocations are Health Care 84.7%, Industrials 1.9%. Versus the prior quarter, allocation shifted toward Other (+10.5pp) and away from Technology (-0.8pp), Consumer Staples (-0.9pp).

Versus the prior quarter, PFM Health Sciences, LP opened 24 new positions, trimmed 28 and fully exited 39, a turnover rate of 75.8% of positions. The portfolio's overlap with the prior quarter was 60% of names.

The largest new positions opened in Q1 2026 were XBI ($58.16M), XLV ($35.03M), ABT ($14.42M).

Of the 39 positions fully exited versus the prior quarter, the largest were ADMA ($23.18M), MDT ($20.54M), MRK ($19.77M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q1 2026)

  • XBI SPDR SERIES TRUST · $58.16M
  • XLV SELECT SECTOR SPDR TR · $35.03M
  • ABT ABBOTT LABORATORIES · $14.42M
  • ACHC ACADIA HEALTHCARE COMPANY IN · $13.63M
  • NTRA NATERA INC · $12.00M
  • HSIC SCHEIN HENRY INC · $11.28M
  • MMSI MERIT MED SYS INC · $11.20M
  • TERN TERNS PHARMACEUTICALS INC · $9.12M

Fully Exited (vs previous quarter)

  • ADMA ADMA BIOLOGICS INC · prev qtr: $23.18M
  • MDT MEDTRONIC PLC · prev qtr: $20.54M
  • MRK MERCK & CO INC · prev qtr: $19.77M
  • UHS UNIVERSAL HLTH SVCS INC · prev qtr: $12.52M
  • TFX TELEFLEX INCORPORATED · prev qtr: $12.50M · history
  • ISRG INTUITIVE SURGICAL INC · prev qtr: $8.73M
  • GILD GILEAD SCIENCES INC · prev qtr: $8.72M
  • CVS CVS HEALTH CORP · prev qtr: $8.55M

Insider Transactions (Form 4)

Latest PFM Health Sciences, LP buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

PFM Health Sciences, LP is an SEC-registered 13F filer based in San Francisco, CA, United States. As of Q2 2026 it reported 96 US equity positions with a combined value of $1.14B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: SAN FRANCISCO, CA, United States
  • SEC registration: 801-69012 (status: Approved), registered 2008-04-10
  • Regulatory AUM (Form ADV): $1.27B as of 2026-03-31
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 4 private funds, of which 2 hedge funds
  • Website: pfmhealthsciences.com

Portfolio Structure

  • 96 positions · $1.14B reported value (Q2 2026)
  • Top 10 holdings = 34.6% of reported value
  • Largest position: ASND (ASCENDIS PHARMA A/S) at 5.4%
  • Average position size: $11.89M

Sector Tilt

  • Health Care 92.9%
  • Industrials 5.1%
  • Consumer Staples 1.2%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 32 new, 24 added, 40 reduced, 14 exited

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 84.7%
Other 13.3%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 398.57K $75.21M 7.61%
7.61%
Hold
2 65.76K $60.49M 6.12%
6.12%
Reduce
3 455.30K $58.16M 5.89%
5.89%
New
4 139.78K $45.90M 4.65%
4.65%
Reduce
5 264.30K $44.67M 4.52%
4.52%
Add
6 238.90K $35.03M 3.54%
3.54%
New
7 178.14K $33.68M 3.41%
3.41%
Add
8 215.68K $28.41M 2.88%
2.88%
Add
9 215.69K $23.22M 2.35%
2.35%
Add
10 528.22K $20.98M 2.12%
2.12%
Reduce
11 305.43K $20.53M 2.08%
2.08%
Add
12 254.51K $20.38M 2.06%
2.06%
Add
13 257.75K $19.14M 1.94%
1.94%
Reduce
14 31.70K $18.80M 1.90%
1.90%
Reduce
15 34.15K $17.87M 1.81%
1.81%
Add
16 574.67K $17.52M 1.77%
1.77%
Add
17 58.04K $15.70M 1.59%
1.59%
Add
18 172.14K $14.45M 1.46%
1.46%
Add
19 140.43K $14.42M 1.46%
1.46%
New
20 140.77K $13.69M 1.39%
1.39%
Reduce
21 582.75K $13.63M 1.38%
1.38%
New
22 1.78M $13.24M 1.34%
1.34%
Add
23 169.83K $12.14M 1.23%
1.23%
Add
24 60.00K $12.00M 1.22%
1.22%
New
25 135.08K $11.89M 1.20%
1.20%
Add
26 136.62K $11.88M 1.20%
1.20%
Add
27 39.76K $11.84M 1.20%
1.20%
Reduce
28 930.10K $11.56M 1.17%
1.17%
Reduce
29 35.44K $11.42M 1.16%
1.16%
Add
30 153.11K $11.28M 1.14%
1.14%
New
31 165.93K $11.23M 1.14%
1.14%
Add
32 162.47K $11.20M 1.13%
1.13%
New
33 324.96K $10.31M 1.04%
1.04%
Add
34 59.43K $9.48M 0.96%
0.96%
Add
35 149.73K $9.40M 0.95%
0.95%
Reduce
36 172.96K $9.12M 0.92%
0.92%
New
37 263.49K $8.63M 0.87%
0.87%
Reduce
38 263.11K $8.56M 0.87%
0.87%
Add
39 174.05K $8.54M 0.86%
0.86%
New
40 406.25K $8.50M 0.86%
0.86%
New
41 248.18K $8.31M 0.84%
0.84%
Hold
42 187.34K $7.98M 0.81%
0.81%
Add
43 1.37M $7.56M 0.77%
0.77%
Add
44 14.83K $7.29M 0.74%
0.74%
Reduce
45 197.18K $7.25M 0.73%
0.73%
New
46 21.96K $7.21M 0.73%
0.73%
Reduce
47 174.87K $7.03M 0.71%
0.71%
Add
48 88.07K $6.95M 0.70%
0.70%
Add
49 31.94K $6.75M 0.68%
0.68%
Reduce
50 57.50K $6.36M 0.64%
0.64%
Reduce

FAQ

What did PFM Health Sciences, LP buy in 2026-Q1?

In its 2026-Q1 13F filing, PFM Health Sciences, LP reported 78 equity positions worth $987.91M in aggregate; its largest disclosed positions were THC ($75.21M), LLY ($60.49M), XBI ($58.16M).

How large is PFM Health Sciences, LP's portfolio?

PFM Health Sciences, LP reported $987.91M of long equity holdings across 78 positions as of 2026-Q1. Top-10 holdings account for 43.1% of reported value.

What is PFM Health Sciences, LP's investment style?

HoldingsHub classifies the portfolio as Small / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/pfm-health-sciences/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →